Learn More
Medchemexpress LLC Endoxifen (hydrochloride) | 1197194-41-4 | 98.0% | 409.95 | 100 MG

Supplier: Medchemexpress LLC HY18719B100MG
Endoxifen hydrochloride is a key active metabolite of Tamoxifen with higher affinity and specificity to estrogen receptor that also inhibits aromatase activity. It has potential for breast cancer study.
- More potent ER antagonist than tamoxifen.
- Induces ER-alpha degradation and inhibits ER transcriptional activity.
- Targets estrogen receptor α for degradation in breast cancer cells, inhibiting proliferation.
- Exhibits strong growth inhibitory and cytotoxic effects on breast cancer cell lines at 10 μM.
- Rapidly absorbed and systemically available; leads to higher exposure levels than tamoxifen.
- Safe and effective in inhibiting human mammary tumor xenografts in female mice orally.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.